| Substitute fused imidazole derivatives, pharmaceutical compositions, and … |
2023-4-03 |
2023-10-05 |
|
| Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4 yl) … |
2022-10-27 |
2023-6-15 |
|
| Solid composition of glp-1 receptor agonist |
2022-9-27 |
2023-4-06 |
|
| Solid compositions comprising a glucokinase activator and methods of making and … |
2021-9-21 |
2022-7-28 |
|
| Amorphous form of isoquinoline derivative |
2021-9-17 |
2022-7-16 |
|
| Substituted fused imidazole derivatives, pharmaceutical compositions, and … |
2021-8-11 |
2023-5-16 |
2023-5-16 |
| Crystalline form of hydrochloride salt of quinoline derivative |
2021-7-26 |
2023-10-05 |
|
| Crystal forms of hydrochloride of quinoline derivative |
2021-7-26 |
2023-8-01 |
|
| Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, … |
2021-7-16 |
2022-3-10 |
|
| Substituted Fused Imidazole Derivatives and Methods of Treating Sickle Cell … |
2021-7-13 |
2021-11-04 |
|
| Quinoline derivatives, pharmaceutically acceptable salts, and methods of use … |
2021-6-29 |
2022-3-01 |
|
| Crystalline forms of {2-[3-cyclohexyl-3-(trans-4-propoxy- cyclohexyl)-ureido]- … |
2021-6-07 |
2023-4-12 |
|
| Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido] … |
2021-6-07 |
2023-4-12 |
|
| Methods of Inhibiting Osteoclastogenesis and Osteoclast Activity |
2021-6-01 |
2021-9-16 |
|
| Intermediates and methods for preparing a glp-1 receptor agonist |
2021-5-26 |
2021-12-02 |
|
| Methods for preparing methyl (s)-2-amino-3-(4-(2,3-dimethylpyridin-4-yl)phenyl) … |
2021-5-26 |
2021-12-02 |
|
| Methods of treating cognitive impairment or improving cognitive function |
2021-4-21 |
2021-11-04 |
|
| Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists |
2021-3-09 |
2022-8-23 |
2022-8-23 |
| Therapeutic uses of glucokinase activators in combination with insulin or … |
2021-2-18 |
2021-6-10 |
|
| Sulfoxide and sulfone glucokinase activators and methods of use thereof |
2021-2-12 |
2021-8-26 |
|
| Substituted fused imidazole derivatives and methods of treating refractive … |
2021-2-01 |
2021-8-12 |
|
| Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical … |
2020-11-20 |
2021-3-11 |
|
| Therapeutic uses of glp1r agonists |
2020-10-13 |
2021-1-28 |
|
| Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)- … |
2020-9-24 |
2021-3-04 |
|
| Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h- … |
2020-9-14 |
2021-3-11 |
|
| Glucokinase activator compositions for the treatment of diabetes |
2020-1-16 |
2020-5-07 |
|
| Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors |
2019-7-10 |
2019-11-07 |
|
| Methods for self-adaptive time series forecasting, and related systems and … |
2019-7-09 |
2022-2-15 |
2022-2-15 |
| Treatment of mild and moderate Alzheimer's disease |
2019-5-23 |
2019-9-26 |
|
| Treatment of Mild and Moderate Alzheimer's Disease |
2019-1-08 |
2019-5-16 |
|
| Substituted Imidazole Derivatives and Methods of Use Thereof |
2018-11-09 |
2019-3-14 |
|
| Piperidine Derivative and Methods of Use Thereof |
2018-8-22 |
2018-12-20 |
|
| Compositions comprising metformin and a glucokinase activator |
2018-8-08 |
2019-7-30 |
2019-7-30 |
| Inhibitors of hexokinase and methods of use thereof |
2017-7-05 |
2018-1-11 |
|
| Compounds That Modulate Oxidative Stress |
2016-8-25 |
2017-7-06 |
|
| Inhibitors of hexokinase and methods of use thereof |
2016-6-03 |
2016-12-08 |
|
| Stable glucokinase activator compositions |
2016-2-18 |
2016-7-15 |
|
| Combinations of a glpir agonist and metformin and use thereof for the treatment … |
2015-11-13 |
2016-4-22 |
|
| Phenylglyoxylic acid derivatives and their preparation and use |
2015-9-15 |
2016-1-07 |
|
| Methods of treatment using fusion proteins |
2015-4-14 |
2015-7-30 |
|
| Substituted azoanthracene derivatives and intermediates for preparation thereof |
2015-1-23 |
2015-11-03 |
2015-11-03 |
| Oxadiazoanthracene compounds for the treatment of diabetes |
2014-12-01 |
2015-9-01 |
2015-9-01 |
| Tris(hydroxymethyl)Aminomethane Salts of a Small-Molecule GLP1R Agonist and … |
2014-9-18 |
2015-1-01 |
|
| N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase |
2014-7-02 |
2014-12-09 |
2014-12-09 |
| Ligands for the GLP-1 Receptor and Methods for Discovery Thereof |
2014-5-01 |
2014-9-25 |
|
| Phenyl-Heteroaryl Derivatives and Methods of Use Thereof |
2014-3-26 |
2014-7-24 |
|
| Aryl carbonyl derivatives as therapeutic agents |
2013-12-20 |
2015-9-15 |
2015-9-15 |
| Benzazole derivatives, compositions, and methods of use as beta-secretase … |
2013-10-28 |
2015-2-03 |
2015-2-03 |
| Glucokinase activator compositions for the treatment of diabetes |
2013-5-15 |
2018-3-23 |
|
| Benzothiazoles Having Histamine H3 Receptor Activity |
2012-10-25 |
2013-3-28 |
|
| Histamine H3 receptor antagonists |
2012-10-22 |
2012-11-15 |
|
| Substituted fused imidazole derivatives, pharmaceutical compositions comprising … |
2012-7-12 |
2016-11-30 |
|
| Novel Medicaments |
2012-5-15 |
2012-9-13 |
|
| Phenoxy acetic acids as PPAR delta activators |
2012-5-08 |
2013-4-23 |
2013-4-23 |
| Urea Glucokinase Activators |
2012-3-08 |
2012-6-28 |
|
| Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase … |
2012-3-06 |
2012-8-02 |
|
| Urea glucokinase activators |
2011-12-21 |
2012-1-19 |
|
| Phenoxy acetic acids as PPAR delta activators |
2011-11-22 |
2011-12-15 |
|
| Benzazole derivatives, compositions, and methods of use as B-secretase … |
2011-10-28 |
2011-11-24 |
|
| Substituted pyridine derivatives, pharmaceutical compositions, and methods of … |
2011-10-21 |
2012-3-22 |
|
| 3- (1, 3-benzodioxol-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its … |
2011-10-14 |
2011-11-03 |
|
| Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
2011-10-10 |
2012-4-12 |
|
| Mono- and bicyclic azole derivatives that inhibit the interaction of ligands … |
2011-9-30 |
2011-10-20 |
|
| 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds |
2011-9-19 |
2012-1-05 |
|
| 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds |
2011-9-16 |
2012-1-12 |
|
| Pharmaceutical use of substituted amides |
2011-8-30 |
2011-12-22 |
|
| Substituted isoquinoline derivatives, pharmaceutical compositions, and methods … |
2011-8-22 |
2012-4-26 |
|
| Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, … |
2011-8-22 |
2012-4-26 |
|
| Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and … |
2011-7-25 |
2013-8-20 |
2013-8-20 |
| Nucleic acid molecules encoding rage fusion proteins |
2011-6-13 |
2013-1-01 |
2013-1-01 |
| Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, … |
2011-3-21 |
2011-9-29 |
|
| Rage Fusion Proteins And Methods Of Use |
2011-2-17 |
2011-10-06 |
|
| Heteroaromatic glucokinase activators |
2011-2-08 |
2011-6-02 |
|
| Crystalline forms of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol … |
2010-12-30 |
2013-2-12 |
2013-2-12 |
| Urea Glucokinase Activators |
2010-12-07 |
2011-3-31 |
|
| Benzamide glucokinase activators |
2010-12-06 |
2011-9-22 |
|
| Substituted Azole Derivatives as Therapeutic Agents |
2010-12-01 |
2011-3-31 |
|
| Substituted Azole Derivatives, Compositions, and Methods of Use |
2010-11-19 |
2011-4-21 |
|
| Heteroaryl-ureas and their use as glucokinase activators |
2010-11-09 |
2011-3-10 |
|
| Rage fusion protein compositions and methods of use |
2010-10-19 |
2012-12-26 |
|
| Probes, Systems, and Methods for Drug Discovery |
2010-10-08 |
2011-2-17 |
|
| Immunoglobulin Fusion Proteins and Methods of Making |
2010-10-06 |
2011-5-12 |
|
| N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase … |
2010-9-30 |
2012-4-03 |
2012-4-03 |
| Histamine H3 Receptor Ligands |
2010-9-16 |
2011-1-13 |
|
| Solid compositions comprising an oxadiazoanthracene compound and methods of … |
2010-9-02 |
2011-3-17 |
|
| Carboxamide Derivatives As Therapeutic Agents |
2010-7-20 |
2010-11-11 |
|
| Substituted piperidines |
2010-5-13 |
2010-9-02 |
|
| Novel Compounds, Their Preparations and Use |
2010-4-30 |
2010-8-19 |
|
| Novel compounds and their use as PPAR-modulators |
2010-4-19 |
2010-5-06 |
|
| RAGE fusion proteins and methods of use |
2010-4-16 |
2010-5-06 |
|
| Pharmaceutical use of fused 1,2,4-triazoles |
2010-4-14 |
2010-8-05 |
|
| Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase … |
2010-2-10 |
2010-6-17 |
|
| Novel compounds, their preparation and use |
2010-1-18 |
2012-2-23 |
|
| Novel aryl-and heteroarylpiperazines |
2010-1-13 |
2010-2-04 |
|
| 11Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds |
2009-12-17 |
2010-5-13 |
|
| Novel salicylic anilides |
2009-11-24 |
2010-3-25 |
|
| Adamantyl benzamide compounds |
2009-11-17 |
2017-4-25 |
2017-4-25 |
| Benzimidazole derivative as therapeutic agent |
2009-9-25 |
2010-2-25 |
|
| Substituted aminothiazole derivatives, pharmaceutical compositions, and methods … |
2009-8-25 |
2011-5-18 |
|
| Amide Derivatives and Pharmaceutical Use Thereof |
2009-6-29 |
2009-10-22 |
|